𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5

✍ Scribed by Daina Z. Ewton; Sharon A. Coolican; Subburaman Mohan; Steven D. Chernausek; James R. Florini


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
213 KB
Volume
177
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


We have previously shown that the insulin-like growth factors (IGFs) stimulate both proliferation and differentiation of skeletal muscle cells in culture, and that these actions in L6A1 muscle cells may be modulated by three secreted IGF binding proteins (IGFBPs), IGFBP-4, -5, and -6. Since we found that the temporal expression pattern of IGFBP-4 and IGFBP-5 differed dramatically during the transition from proliferating myoblasts to differentiated myotubes, we undertook the current study to examine the effects of purified IGFBP-4 and IGFBP-5 on IGFstimulated actions in L6A1 muscle cells. As has been shown for other cell types, we found that IGFBP-4 had only inhibitory actions, inhibiting IGF-I and IGF-IIstimulated proliferation and differentiation. In contrast, IGFBP-5 exhibited both inhibitory and stimulatory actions. When added in the presence of 30 ng/ml IGF-I, IGFBP-5 (250 ng/ml) inhibited all markers of the early proliferative response: the tyrosine phosphorylation of the cytoplasmic signaling molecules IRS-1 and Shc, the activation of the MAP kinases, ERK1 and 2, the elevation of c-fos mRNA, the early inhibition of the elevation in myogenin mRNA, and the increase in cell number. In contrast, IGFBP-5 stimulated all aspects of the myogenic response to IGF-I: the later rise in myogenin mRNA, the elevation of creatine kinase activity, and the fusion of myoblasts into myotubes. This dual response to IGFBP-5 was greatest when it was added at a molar ratio of IGFBP-5 to IGF-I of 2:1. In contrast, when IGFBP-5 was added in the presence of IGF-II, it inhibited both proliferation and differentiation. Neither IGFBP had any effect when added in the presence of R3 IGF-I, an analog with substantially reduced affinity for IGFBPs. Our results suggest that the role of IGFBP-4 is mainly to sequester excess IGFs, and thus inhibit all actions. IGFBP-5, however, is capable of eliciting a dual response, possibly due to its unique ability to associate with the cell membrane.


πŸ“œ SIMILAR VOLUMES


Expression of insulin-like growth factor
✍ Stephanie R. Edmondson; Mari M. Murashita; Vincenzo C. Russo; Christopher J. Wra πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 195 KB πŸ‘ 1 views

Insulin-like growth factor-I (IGF-I) is essential for normal epidermal homeostasis; however, the role of IGF binding proteins (IGFBPs), regulators of IGF action, remains unclear. Here we examine the regulation of human keratinocyte-produced IGFBPs by epidermal growth factor (EGF), transforming growt

Osteogenic protein-1 regulates insulin-l
✍ Lee-Chuan C. Yeh; Martin L. Adamo; Cunming Duan; John C. Lee πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 272 KB πŸ‘ 1 views

Osteogenic protein-1 (OP-1 or BMP-7) stimulates new bone formation in vivo and induces cell proliferation and differentiation of osteoblasts in vitro. Previous studies from our laboratory revealed that OP-1 led to a two-to threefold increase in steady-state insulin-like growth factor-I (IGF-I) and I

Tumor necrosis factor-α–induced apoptosi
✍ Kate A. Meadows; Jeff M.P. Holly; Claire E.H. Stewart πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 264 KB

Wasting of muscle and fat during cachexia exceeds that explained by reduced food intake alone. This wasting may result from an imbalanced cytokine environment, which could lead to increased protein catabolism. Supporting this, tumor necrosis factor-alpha (TNF-alpha) is raised in several animal model

Insulin-like growth factor (IGF)–binding
✍ Marjorie Baciuchka; Maryse Remacle-Bonnet; FranΓ§oise Garrouste; Roger Favre; Ber πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 186 KB πŸ‘ 1 views

The limited proteolysis of insulin-like growth factor (IGF)binding protein (IGFBP)-3 is a key event in the regulation of endocrine bioavailability of IGFs. Here, we investigated IGFBP-3 and IGFBP-3 proteolysis in serum from patients with colorectal cancer both before and at different times following

Surface-bound plasmin induces selective
✍ Maryse M. Remacle-Bonnet; FranΓ§oise L. Garrouste; Gilbert J. Pommier πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 162 KB πŸ‘ 1 views

Limited proteolysis of insulin-like-growth-factor (IGF)-binding proteins (IGFBPs) represents a key process to modulate IGF bio-availability at the cellular level. In human colon carcinomas, urokinase-type plasminogen activator (u-PA) produced by stroma cells can bind to cancer-cell-associated u-PA r